Sort
261,768 grants matching “gene therapy”
Monthly Antiretroviral Therapy Using Multispecific HIV Neutralizing Antibodies
$890,000David D Ho · Aaron Diamond Aids Research Center · DP1 · FY2014 · DA
In vivo hematopoietic stem cell genetic modification by viral particles
$889,998Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2024 · HL
Exonuclease Epigenetic Sequencing
$889,978Eric Ervin · Electronic Biosciences, Inc. · R44 · FY2019 · HG
Treating the CNS and Somatic Diseases of MPS IIB Systemic Gene Delivery
$889,963Haiyan Fu · Research Inst Nationwide Children'S Hosp · U01 · FY2011 · NS
Molecular Genetics Of Scrapie Pathogenesis
$889,806Suzette Alise Priola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Receptor-directed Therapy
$889,774John Janik · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
$889,701Farhad Parhami · Max Biopharma, Inc. · R44 · FY2024 · DK
The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)
$889,680Gregory D Kirk · Johns Hopkins University · R01 · FY2009 · HL
Lead optimization of a novel cyclic aryl-indole efflux pump inhibitor (EPI) series in combination with levofloxacin against Pseudomonas aeruginosa
$889,610Ajit K Parhi · Taxis Pharmaceuticals, Inc. · R44 · FY2025 · AI
Clinical development of mechanism-based lymphoma therapies
$889,551Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
NOVEL METHODS FOR IMAGING PET BIOMARKERS AND GENE THERAPY OF CANCER
$889,530University Of Tennessee · · FY2008 · Department of Defense
Therapeutic Targeting of Malignant Glioma Stem Cells
$889,484Maciej S Lesniak · Northwestern University At Chicago · R35 · FY2019 · CA
De novo copy number variation and gene discovery in human brain malformations
$889,449William B Dobyns · University Of Chicago · R01 · FY2009 · NS
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
$889,363Sephira Ryman · Lovelace Biomedical Research Institute · R01 · FY2025 · NS
Observation Study of Persons with Chronic Hepatitis B Virus infection in North America
$889,332Harry Janssen · University Health Network · U01 · FY2016 · DK
Indiana PREGMED
$889,326David M. Haas · Indiana University Indianapolis · U10 · FY2014 · HD
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$889,289Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice
$889,277Susana T Valente · University Of Florida · R01 · FY2024 · AI
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
$889,216Robert C Bast · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA
Next Generation Cancer Immunotherapies to Defeat Melanoma
$889,199Antoni Ribas · University Of California Los Angeles · R35 · FY2024 · CA
Alzheimer's disease genetic architecture in the Portuguese population
$889,196Rita Guerreiro · Van Andel Research Institute · R01 · FY2022 · AG
Development and Use of Network Infrastructure for High-Throughput GWA Studies
$889,184Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2010 · HG
Novel Methodology for Quantitative High-throughput Cancer Epigenetics
$889,149Benjamin A Garcia · Princeton University · DP2 · FY2010 · OD
Delivery of CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides
$889,032Paul B McCray · University Of Iowa · UH3 · FY2022 · HL
Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus
$888,853Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2009 · HL